← Back to Search

Diagnostic Test

Pediatric Participants with GAS for Streptococcal Infections

N/A
Recruiting
Led By Gregory DeMuri, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 (up to 40 minutes)
Awards & highlights

Study Summary

This trial will test a new platform for detecting Group A Streptococcus in children ages 5-17. The platform, called LolliTest, will be compared to the current gold-standard test.

Who is the study for?
This trial is for children aged 5-17 with a sore throat caused by Group A Streptococcus (GAS), confirmed by a rapid test at the clinic. They must be able to understand and complete surveys in English, as should their parents or guardians who consent on their behalf. Children sensitive to sugar-free products or unable to use the CandyCollect swab are excluded.Check my eligibility
What is being tested?
The study tests the CandyCollect platform's ability to detect GAS from a lollipop-like swab compared to standard rapid antigen testing. It aims to prove that this new, kid-friendly method is just as accurate for diagnosing strep throat during a single clinic visit.See study design
What are the potential side effects?
Since the intervention involves using a non-invasive candy-like swab, side effects may include discomfort from sucking on the swab and potential issues for those with sensitivity to sugar-free products.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 (up to 40 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (up to 40 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of test results positive for GAS
Secondary outcome measures
Caregiver Experience Score (Bad/Good)
Caregiver Experience Score (Pleasant/Unpleasant)
Caregiver Sample Collection Preference
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pediatric Participants with GASExperimental Treatment2 Interventions
Children age 5-17 years old diagnosed via standard Rapid Antigen Detection Test with acute pharyngitis caused by Group A Streptococcus (GAS), along with their parent or legal guardian (aka "caregiver").

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,192 Previous Clinical Trials
3,161,887 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,714 Previous Clinical Trials
7,511,193 Total Patients Enrolled
Gregory DeMuri, MDPrincipal InvestigatorUniversity of Wisconsin, Madison
1 Previous Clinical Trials
180 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to become a subject in this experiment?

"This research trial is seeking 70 children aged 5-17 with a diagnosis of streptococcal pharyngitis, as evidenced by a positive RADT swab. Furthermore, those involved must be able to provide consent and answer surveys in English."

Answered by AI

Are participants of this experiment required to be over the age of 18?

"This clinical trial is enrolling participants aged 5 to 17."

Answered by AI

Is this research still accepting participants?

"As per clinicaltrials.gov, this medical experiment has ceased recruiting patients since November 30th 2022. That said, 8 other trials are still currently welcoming applicants."

Answered by AI
~57 spots leftby May 2025